CytomX Therapeutics, Inc.CytomX Therapeutics, Inc.CytomX Therapeutics, Inc.

CytomX Therapeutics, Inc.

No trades
No trades

Fundamentals and stats

EPS and revenue snapshot

In the last quarter, the company reported −0.10 USD per share, beating the −0.12 USD estimate by 17.42%. Revenue for the same period reached ‪10.26 M‬ USD, despite the estimate of ‪4.68 M‬ USD. For the next quarter, analysts expect −0.08 USD in earnings per share and ‪12.39 M‬ USD in revenue.

Next report date
Report period
EPS estimate
Revenue estimate
EPS
Reported
Estimate
Metrics
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Metrics
Reported
Estimate
Surprise